SaifM. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas, v. 14, n. 6, p. 686-688, 10 nov. 2013.